Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01366963 · ClinicalTrials.gov registry record

Cognitive Dysfunction in Postural Tachycardia Syndrome

A clinical trial of Postural Tachycardia Syndrome, sponsored by Vanderbilt University.

Completed
Registry status
60
Enrollment target
1
Study location

NCT01366963 is a study of Postural Tachycardia Syndrome that has completed, run by Vanderbilt University. The registered enrollment target is 60 participants, below the 79-participant average among 19 other Postural Tachycardia Syndrome trials with a reported enrollment target (24% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01366963, a study of Postural Tachycardia Syndrome, has completed, sponsored by Vanderbilt University.

COMPLETED
Registry status
60 participants
Enrollment target
1
Study location

Study Summary

A common complaint among people with Postural Tachycardia Syndrome (POTS) is "brain fog" or difficulty concentrating. This is very poorly understood. To better understand this cognitive dysfunction, the investigators will test people with POTS and people without POTS using various neuropsychiatric instruments. The investigators hypothesis is that people with POTS will have greater abnormalities on neuropsychiatric testing than normal controls.

Interventions

  • BEHAVIORAL Seated Measurements
  • BEHAVIORAL Standing Measurements
  • BEHAVIORAL Self-Administered Surveys

Study Locations (1)

Tennessee

  • Vanderbilt University - Nashville

Trial Details

FieldValue
Enrollment Target 60 participants
Start Date 2011-03
Est. Completion 2015-06

Sponsor

Vanderbilt University

430 total trials

What the Registry Record Tells You About NCT01366963

The ClinicalTrials.gov registry entry for NCT01366963 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 60 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 79-participant average among 19 other Postural Tachycardia Syndrome trials with a reported enrollment target (24% lower). The listed sponsor is Vanderbilt University, which has 430 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Postural Tachycardia Syndrome appearing as the primary indexed condition, and to 3 interventions - of which Seated Measurements is the first listed.

NCT01366963 reports 1 study location spanning 1 distinct geographic area - top geographies include Tennessee.

Frequently Asked Questions

What is clinical trial NCT01366963 about?

NCT01366963 is a clinical study titled "Cognitive Dysfunction in Postural Tachycardia Syndrome". A common complaint among people with Postural Tachycardia Syndrome (POTS) is "brain fog" or difficulty concentrating. This is very poorly understood. To better understand this cognitive dysfunction, the investigators will test people with POTS and people without POTS using various neuropsychiatric i...

What is the current status of trial NCT01366963?

This trial is currently completed. The enrollment target is 60 participants. The study started on 2011-03. Estimated completion is 2015-06.

What conditions does trial NCT01366963 study?

This clinical trial studies the following conditions: Postural Tachycardia Syndrome.

What interventions are being tested in trial NCT01366963?

The interventions under investigation include: Seated Measurements (BEHAVIORAL), Standing Measurements (BEHAVIORAL), Self-Administered Surveys (BEHAVIORAL).

Who is sponsoring clinical trial NCT01366963?

This trial is sponsored by Vanderbilt University, which has 430 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01366963 being conducted?

This trial has 1 study location across Tennessee. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Postural Tachycardia Syndrome

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.